- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Alector Inc (ALEC)
The Alector share price today is 2.36, view NASDAQ ALEC stock exchange data. Track the latest Alector share price with real-time updates on ALEC stock performance including market cap, day range, 52-week range and dividend yield. Access ALEC charts, earnings dates and analyst estimates to support your investment decisions.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.29
2.38
52 wk Range
0.97
3.40
Earnings results expected tomorrow
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.292.38
52 wk Range
0.973.40
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ALEC Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Neutral
Price Target
2.88
Upside
+22.03%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
- Form S-3 Alector Inc For: 13 March
- Investing.com
- Alector Inc receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Form 144 ALECTOR For: 10 March
- Investing.com
- Alector Inc receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Alector Inc receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Strong Sell
Analyst Ratings
3 Buy
3 Hold
2 Sell
Ratings:
8 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 2.88
(+22.03% Upside)
Alector Inc Earnings Call Summary for Q2/2025
- Alector beats Q2 2025 forecasts: EPS of -$0.30 vs -$0.47 expected, revenue of $7.9M vs $4.7M anticipated
- Strong cash position of $307.3M expected to last into 2027; stock up 2.1% after hours to $1.46
- Phase III trial of Latozinimab for FTD and Phase II for Alzheimer's progressing; results expected mid-Q4 2025
- 2025 guidance: Collaboration revenue $13-18M, R&D expenses $130-140M; focus on neurodegenerative therapies
- Challenges include regulatory hurdles, market competition, and maintaining financial sustainability
Last Updated: 08-08-2025, 04:06 pm
Read Full TranscriptEarnings
Latest Release
26-02-2026
EPS / Forecast
-0.34 / -0.39
Revenue / Forecast
6.2M / 2.38M
Compare ALEC to Peers and Sector
Metrics to compare | ALEC | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipALECPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.8x | −2.2x | −0.5x | |
PEG Ratio | 0.14 | −0.05 | 0.00 | |
Price/Book | 8.5x | 2.7x | 2.6x | |
Price / LTM Sales | 12.4x | 55.2x | 3.2x | |
Upside (Analyst Target) | −36.4% | 94.8% | 48.1% | |
Fair Value Upside | Unlock | 5.3% | 6.6% | Unlock |
Alector, Inc., a clinical stage biotechnology company, develops therapies to counteract the progression of neurodegeneration in the United States. Its pipeline includes Nivisnebart, an investigational human recombinant monoclonal antibody for treating prevalent neurodegenerative diseases; AL137, an anti-amyloid beta antibody paired in preclinical development for the potential treatment of Alzheimer’s disease; and AL050, a GCase enzyme replacement therapy in preclinical development for the potential treatment of Parkinson’s disease and Lewy body dementia in patients having GBA1 gene mutations. The company also develops its preclinical and research pipeline comprising AL064, a tau siRNA for Alzheimer’s disease and other tauopathies; ADP062-ABC, an alpha-synuclein siRNA for Parkinson’s disease; and ADP065-ABC, an NLRP3 siRNA for neurodegenerative conditions. It has a strategic collaboration agreement with GlaxoSmithKline plc for the development and commercialization of progranulin-elevating monoclonal antibodies, including Latozinemab and Nivisnebart. The company was founded in 2013 and is headquartered in South San Francisco, California.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Alector (ALEC) Share Price Today?
The Alector share price today is 2.36.
What is the current Alector (ALEC) share price and day range?
As of 03-05-2026, the Alector share price is 2.36, with a previous close of 2.37. The share price has ranged from 2.29 to 2.38 today, while the 52-week range spans from 0.97 to 3.40.
What Is the Alector Market Cap?
As of today, Alector market cap is 260.46M.
What Is the Alector (ALEC) Share Price Target?
The average 12-month share price target for Alector is 2.88, with a high estimate of 6 and a low estimate of 0.9. 3 analysts recommend buying, while 2 suggest selling, with an overall rating of Neutral and +22.03% Upside potential.
What Is Alector's Earnings Per Share (TTM)?
The Alector EPS (TTM) is -1.39.
When Is the Next Alector Earnings Date?
Alector will release its next earnings report on 04-05-2026.
From a Technical Analysis Perspective, Is ALEC a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
What Stock Exchange Does Alector Trade On?
Alector is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Alector?
The stock symbol for Alector is "ALEC."
How Many Times Has Alector Stock Split?
Alector has split 0 times.
How Many Employees Does Alector Have?
Alector has 103 employees.
What Is the ALEC Premarket Price?
ALEC's last pre-market stock price is 2.28. The pre-market share volume is 400.00, and the stock has changed by -0.09, or -3.80%.
What Is the ALEC After Hours Price?
ALEC's last after hours stock price is 2.32, the stock has changed by -0.04, or -1.69%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.